Myanmar

in page functions
[French]
Total population (2014) 53,718,958
Birth cohort (2014) 910,529
Surviving Infants (surviving to 1 year per year, 2014) 867,070
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 40/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 51/1000
Co-financing status (2013) Low-income
No. of districts/territories (2013) 330

Gavi support for Myanmar

Type of support

Approvals

2001-2020 (US$)
(30 Sep 2014)

Commitments

2001-2020 (US$)
(30 Sep 2014)

Disbursements

2000-2014 (US$)
(30 Sep 2014)

% Disbursed

(30 Sep 2014)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Health system strengthening (HSS 1) $32,770,639 $32,770,639 $18,190,862 56%
HepB mono (NVS) $13,833,610 $13,833,610 $13,833,610 100%
Immunisation services support (ISS) $7,707,080 $7,707,080 $7,707,080 100%
Injection safety support (INS) $2,083,978 $2,083,978 $2,083,978 100%
Measles (NVS) $2,117,000 $2,816,500 $2,596,851 123%
Measles-Rubella (NVS) $13,960,500 $13,960,500 $12,916,448 93%
MR - Operational costs (OPC) $11,357,500 $11,357,500
Penta (NVS) $33,701,531 $45,510,031 $16,563,513 49%
Pneumo (NVS) $21,509,000 N/A
Vaccine Introduction Grant (VIG) $3,740,000 $3,740,000 $2,518,000 67%
Total $121,271,838 $155,288,838 $76,410,342

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Myanmar DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 75%
M:F sex ratio at birth (2014) 1.03
Household survey: DTP3 coverage for male (2010) 97.80%
Household survey: DTP3 coverage for female (2010) 97.90%
Household survey: Last DTP3 survey (2010) 98%
% districts achieving > 80% DTP3 coverage (2013) 45%
% districts achieving < 50% DTP3 coverage (2013) 8%
MCV WHO/UNICEF estimates (2013) 86%
Polio WHO/UNICEF estimates (2013) 76%

Breakdown of support

Non-vaccine support Vaccine support
39% 61%
$29,290,919 $45,910,421

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Myanmar

20 May 2014

Reasons to invest

Reasons to invest in the GAVI Alliance

From singers and Presidents to Ministers and advocates, GAVI Alliance supporters explain why they are backing the Alliance’s vision for 2020

30 October 2013

MTR group photo final PR

GAVI Alliance partners reaching more children than ever before with accelerated access to vital vaccines

Mid-Term Review meeting highlights immunisation successes and challenges.

30 October 2013

MTR quote John Mahama 2

How we are doing so far?

GAVI partners give a personal take on the Mid-Term Review, immunisation and the Alliance’s performance against its strategic goals

close icon

modal window here